Platelet-rich plasma in the treatment of acute hamstring injuries in professional football players

Giacomo Zanon, Franco Combi, Alberto Combi, Loris Perticarini, Luigi Sammarchi, Francesco Benazzo

Research output: Contribution to journalArticle

Abstract

Purpose: muscle injuries have a high incidence in professional football and are responsible for the largest number of days lost from competition. several in vitro studies have confirmed the positive role of plateletrich plasma (PRP) in accelerating recovery and in promoting muscle regeneration, and not fibrosis, in the healing process. this study examines the results of intralesional administration of PRP in the treatment of primary hamstring injuries sustained by players belonging to a major league football club. Methods: twenty-five hamstring injuries (grade 2 according to MRi classification) sustained by professional football players during a 31-months observation period were treated with PRP and analyzed. sport participation absence (sPA), in days, was considered to correspond to the healing time, and we also considered the re-injury rate, and tissue healing on MRi. the mean follow-up was 36.6 months (range 22-42). Results: there were no adverse events. the mean sPA for the treated muscle injuries was 36.76±19.02 days. the re-injury rate was 12%. tissue healing, evaluated on MRi, was characterized by the presence of excellent repair tissue and a small scar. Conclusions: this study confirmed the safety of PRP in treating hamstring lesions in a large series of professional football players. PRP-treated lesions did not heal more quickly than untreated lesions described in the literature, but they showed a smaller scar and excellent repair tissue. Level of evidence: Level iV, therapeutic case series.

Original languageEnglish
Pages (from-to)17-23
Number of pages7
JournalJoints
Volume4
Issue number1
DOIs
Publication statusPublished - Jan 1 2016

Fingerprint

Platelet-Rich Plasma
Football
Wounds and Injuries
Muscles
Cicatrix
Sports
Regeneration
Fibrosis
Observation
Safety
Incidence

Keywords

  • Football
  • Hamstring healing
  • Injuries
  • Muscle
  • Platelet-rich plasma

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Rehabilitation
  • Surgery

Cite this

Platelet-rich plasma in the treatment of acute hamstring injuries in professional football players. / Zanon, Giacomo; Combi, Franco; Combi, Alberto; Perticarini, Loris; Sammarchi, Luigi; Benazzo, Francesco.

In: Joints, Vol. 4, No. 1, 01.01.2016, p. 17-23.

Research output: Contribution to journalArticle

@article{377b36a8881d40418f0c20aeddd9e71a,
title = "Platelet-rich plasma in the treatment of acute hamstring injuries in professional football players",
abstract = "Purpose: muscle injuries have a high incidence in professional football and are responsible for the largest number of days lost from competition. several in vitro studies have confirmed the positive role of plateletrich plasma (PRP) in accelerating recovery and in promoting muscle regeneration, and not fibrosis, in the healing process. this study examines the results of intralesional administration of PRP in the treatment of primary hamstring injuries sustained by players belonging to a major league football club. Methods: twenty-five hamstring injuries (grade 2 according to MRi classification) sustained by professional football players during a 31-months observation period were treated with PRP and analyzed. sport participation absence (sPA), in days, was considered to correspond to the healing time, and we also considered the re-injury rate, and tissue healing on MRi. the mean follow-up was 36.6 months (range 22-42). Results: there were no adverse events. the mean sPA for the treated muscle injuries was 36.76±19.02 days. the re-injury rate was 12{\%}. tissue healing, evaluated on MRi, was characterized by the presence of excellent repair tissue and a small scar. Conclusions: this study confirmed the safety of PRP in treating hamstring lesions in a large series of professional football players. PRP-treated lesions did not heal more quickly than untreated lesions described in the literature, but they showed a smaller scar and excellent repair tissue. Level of evidence: Level iV, therapeutic case series.",
keywords = "Football, Hamstring healing, Injuries, Muscle, Platelet-rich plasma",
author = "Giacomo Zanon and Franco Combi and Alberto Combi and Loris Perticarini and Luigi Sammarchi and Francesco Benazzo",
year = "2016",
month = "1",
day = "1",
doi = "10.11138/jts/2016.4.1.017",
language = "English",
volume = "4",
pages = "17--23",
journal = "Joints",
issn = "2282-4324",
publisher = "CIC Edizioni Internazionali s.r.l.",
number = "1",

}

TY - JOUR

T1 - Platelet-rich plasma in the treatment of acute hamstring injuries in professional football players

AU - Zanon, Giacomo

AU - Combi, Franco

AU - Combi, Alberto

AU - Perticarini, Loris

AU - Sammarchi, Luigi

AU - Benazzo, Francesco

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Purpose: muscle injuries have a high incidence in professional football and are responsible for the largest number of days lost from competition. several in vitro studies have confirmed the positive role of plateletrich plasma (PRP) in accelerating recovery and in promoting muscle regeneration, and not fibrosis, in the healing process. this study examines the results of intralesional administration of PRP in the treatment of primary hamstring injuries sustained by players belonging to a major league football club. Methods: twenty-five hamstring injuries (grade 2 according to MRi classification) sustained by professional football players during a 31-months observation period were treated with PRP and analyzed. sport participation absence (sPA), in days, was considered to correspond to the healing time, and we also considered the re-injury rate, and tissue healing on MRi. the mean follow-up was 36.6 months (range 22-42). Results: there were no adverse events. the mean sPA for the treated muscle injuries was 36.76±19.02 days. the re-injury rate was 12%. tissue healing, evaluated on MRi, was characterized by the presence of excellent repair tissue and a small scar. Conclusions: this study confirmed the safety of PRP in treating hamstring lesions in a large series of professional football players. PRP-treated lesions did not heal more quickly than untreated lesions described in the literature, but they showed a smaller scar and excellent repair tissue. Level of evidence: Level iV, therapeutic case series.

AB - Purpose: muscle injuries have a high incidence in professional football and are responsible for the largest number of days lost from competition. several in vitro studies have confirmed the positive role of plateletrich plasma (PRP) in accelerating recovery and in promoting muscle regeneration, and not fibrosis, in the healing process. this study examines the results of intralesional administration of PRP in the treatment of primary hamstring injuries sustained by players belonging to a major league football club. Methods: twenty-five hamstring injuries (grade 2 according to MRi classification) sustained by professional football players during a 31-months observation period were treated with PRP and analyzed. sport participation absence (sPA), in days, was considered to correspond to the healing time, and we also considered the re-injury rate, and tissue healing on MRi. the mean follow-up was 36.6 months (range 22-42). Results: there were no adverse events. the mean sPA for the treated muscle injuries was 36.76±19.02 days. the re-injury rate was 12%. tissue healing, evaluated on MRi, was characterized by the presence of excellent repair tissue and a small scar. Conclusions: this study confirmed the safety of PRP in treating hamstring lesions in a large series of professional football players. PRP-treated lesions did not heal more quickly than untreated lesions described in the literature, but they showed a smaller scar and excellent repair tissue. Level of evidence: Level iV, therapeutic case series.

KW - Football

KW - Hamstring healing

KW - Injuries

KW - Muscle

KW - Platelet-rich plasma

UR - http://www.scopus.com/inward/record.url?scp=84978977391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978977391&partnerID=8YFLogxK

U2 - 10.11138/jts/2016.4.1.017

DO - 10.11138/jts/2016.4.1.017

M3 - Article

AN - SCOPUS:84978977391

VL - 4

SP - 17

EP - 23

JO - Joints

JF - Joints

SN - 2282-4324

IS - 1

ER -